TGFB1 and colorectal carcinoma: Elevated levels of PD-L1 were linked to poor prognoses after surgery and correlated with increased expressions of TGF-β and Foxp3 in CRC patients 31, making PD-L1 a prospective therapeutic target for the treatment of CRC.